Skip to main content

Advertisement

We’re sorry, something doesn't seem to be working properly. Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.

Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study

  • Charissa Borja-Tabora1,
  • Cecilia Montalban2,
  • Ziad A Memish3Email author,
  • Marie Van der Wielen4,
  • Veronique Bianco4,
  • Dominique Boutriau4 and
  • Jacqueline Miller5
BMC Infectious Diseases201313:116

DOI: 10.1186/1471-2334-13-116

Received: 23 May 2012

Accepted: 26 February 2013

Published: 5 March 2013

Authors’ Affiliations

(1)
Research Institute for Tropical Medicine
(2)
Philippine General Hospital Manila
(3)
College of Medicine, Alfaisal University
(4)
GlaxoSmithKline Vaccines
(5)
GlaxoSmithKline Vaccines

Advertisement